Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 178

1.

The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy.

Schülke N, Varlamova OA, Donovan GP, Ma D, Gardner JP, Morrissey DM, Arrigale RR, Zhan C, Chodera AJ, Surowitz KG, Maddon PJ, Heston WD, Olson WC.

Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12590-5.

2.

Recombinant glutamate carboxypeptidase II (prostate specific membrane antigen--PSMA)--cellular localization and bioactivity analyses.

Meighan MA, Dickerson MT, Glinskii O, Glinsky VV, Wright GL Jr, Deutscher SL.

J Protein Chem. 2003 May;22(4):317-26.

PMID:
13678295
3.

Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature.

Chang SS, Reuter VE, Heston WD, Bander NH, Grauer LS, Gaudin PB.

Cancer Res. 1999 Jul 1;59(13):3192-8.

4.

A new generation of monoclonal and recombinant antibodies against cell-adherent prostate specific membrane antigen for diagnostic and therapeutic targeting of prostate cancer.

Elsässer-Beile U, Wolf P, Gierschner D, Bühler P, Schultze-Seemann W, Wetterauer U.

Prostate. 2006 Sep 15;66(13):1359-70.

PMID:
16894535
5.
6.

A recombinant PSMA-specific single-chain immunotoxin has potent and selective toxicity against prostate cancer cells.

Wolf P, Gierschner D, Bühler P, Wetterauer U, Elsässer-Beile U.

Cancer Immunol Immunother. 2006 Nov;55(11):1367-73. Epub 2006 Mar 18.

PMID:
16547705
7.

A novel alphavirus vaccine encoding prostate-specific membrane antigen elicits potent cellular and humoral immune responses.

Durso RJ, Andjelic S, Gardner JP, Margitich DJ, Donovan GP, Arrigale RR, Wang X, Maughan MF, Talarico TL, Olmsted RA, Heston WD, Maddon PJ, Olson WC.

Clin Cancer Res. 2007 Jul 1;13(13):3999-4008.

8.

In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen.

Smith-Jones PM, Vallabahajosula S, Goldsmith SJ, Navarro V, Hunter CJ, Bastidas D, Bander NH.

Cancer Res. 2000 Sep 15;60(18):5237-43.

9.

Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer.

Ghosh A, Heston WD.

J Cell Biochem. 2004 Feb 15;91(3):528-39. Review.

PMID:
14755683
10.

Different glycoforms of prostate-specific membrane antigen are intracellularly transported through their association with distinct detergent-resistant membranes.

Castelletti D, Alfalah M, Heine M, Hein Z, Schmitte R, Fracasso G, Colombatti M, Naim HY.

Biochem J. 2008 Jan 1;409(1):149-57.

PMID:
17935484
11.

Anti-prostate specific membrane antigen designer T cells for prostate cancer therapy.

Ma Q, Safar M, Holmes E, Wang Y, Boynton AL, Junghans RP.

Prostate. 2004 Sep 15;61(1):12-25.

PMID:
15287090
12.

Association of prostate-specific membrane antigen with caveolin-1 and its caveolae-dependent internalization in microvascular endothelial cells: implications for targeting to tumor vasculature.

Anilkumar G, Barwe SP, Christiansen JJ, Rajasekaran SA, Kohn DB, Rajasekaran AK.

Microvasc Res. 2006 Jul-Sep;72(1-2):54-61. Epub 2006 May 19.

PMID:
16713605
14.

In vitro and in vivo responses of advanced prostate tumors to PSMA ADC, an auristatin-conjugated antibody to prostate-specific membrane antigen.

Wang X, Ma D, Olson WC, Heston WD.

Mol Cancer Ther. 2011 Sep;10(9):1728-39. doi: 10.1158/1535-7163.MCT-11-0191. Epub 2011 Jul 12.

15.

Potent antitumor activity of an auristatin-conjugated, fully human monoclonal antibody to prostate-specific membrane antigen.

Ma D, Hopf CE, Malewicz AD, Donovan GP, Senter PD, Goeckeler WF, Maddon PJ, Olson WC.

Clin Cancer Res. 2006 Apr 15;12(8):2591-6.

16.

Use of methotrexate-based peptide substrates to characterize the substrate specificity of prostate-specific membrane antigen (PSMA).

Mhaka A, Gady AM, Rosen DM, Lo KM, Gillies SD, Denmeade SR.

Cancer Biol Ther. 2004 Jun;3(6):551-8. Epub 2004 Jun 10.

PMID:
15044850
17.

Apical transport and folding of prostate-specific membrane antigen occurs independent of glycan processing.

Castelletti D, Fracasso G, Alfalah M, Cingarlini S, Colombatti M, Naim HY.

J Biol Chem. 2006 Feb 10;281(6):3505-12. Epub 2005 Oct 12.

18.
19.

Induction of antibodies against prostate-specific membrane antigen (PSMA) by vaccination with a PSMA DNA vector.

Kuratsukuri K, Wang CY, Sone T, Nishisaka N, Jones RF, Haas GP.

Eur Urol. 2002 Jul;42(1):67-73.

PMID:
12121733
20.
Items per page

Supplemental Content

Write to the Help Desk